Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Fast payday loans online - payday loans UK up to 1000 pounds.
Popular Articles

Study Could Help Target New Pancreatitis Treatments
Pancreatitis is often a fatal condition, in which the pancreas digests itself and surrounding tissue. Scientists have previously found that alcohol can trigger the condition by combining with fatty acids in the pancreas, which leads to an excessive release of stored calcium ions. Once calcium ions enter cell fluid in the pancreas it activates digestive enzymes and damages the cells.
generic viagra online
New UCLA Method Predicts Which Brain Tumors Will Respond To Avastin
UCLA researchers have uncovered a new way to scan brain tumors and predict which ones will be shrunk by the drug Avastin - before the patient ever starts treatment. By linking high water movement in tumors to positive drug response, the UCLA team predicted with 70 percent accuracy which patients" tumors were the least likely to grow six months after therapy.
News of the day
University Of Pittsburgh Medical Center Named One Of 100 Most Wired Hospitals In The U.S. For 11th Consecutive Year
For the 11th consecutive year, the University of Pittsburgh Medical Center (UPMC) has been named one of the 100 Most Wired hospitals and health systems in the United States, according to the results of the 2009 survey by Hospitals & Health Networks magazine, the journal of the American Hospital Association. UPMC is one of only five organizations to appear on the list since its inception.
Cardiovascular

Motor Neurone Disease: New Stem Cell Research Could Make Lab Mice Redundant

Researchers from the University of Bath are embarking on a project to use stem cell technology that could reduce the number of animal experiments used to study conditions such as motor neurone disease. Dr Vasanta Subramanian, from the University"s Department of Biology & Biochemistry, will be developing a technique using human stem cells to study this debilitating neurological disease, greatly reducing the number of animals used in research. Stem cells are the precursor cells that are able to develop into more specialised cells and tissues such as neurones or skin cells. Whilst previously most stem cells were derived from embryos, this new research project will instead use Induced Pluripotent Stem cells (iPS cells) which are made from skin cells from adults. Dr Subramanian has been awarded a major three year grant by the National Centre for Replacement, Refinement & Reduction of Animals in Research (NC3Rs) to study ALS, a form of motor neurone disease in which the nerve cells that control the muscles die. This currently incurable condition causes patients to lose movement in muscles, affecting breathing and eventually causing death. Dr Subramanian will be making iPS cells from the skin cells of patients suffering from ALS to study the genes that are thought to cause the disease. She said: "These are exciting times for stem cell research and there is tremendous potential in the iPS cell technology both for medical applications and in basic biology. "This technology will not only help understand the mechanisms underlying the disease, but will also reduce the numbers of animals used in research. "There is a real need to develop alternative methods for studying these diseases that are more robust and better simulate how the disease develops in humans." The grant will fund a teaching replacement for Dr Subramanian, allowing her to focus on her research, and a research assistant to work on the project. It will also fund a state-of-the-art high power microscope that will allow the researchers to observe the movements and growth of neurones in real time. The project is one of 13 receiving a share of a ÷£4.5 million fund from the NC3Rs. Dr Vicky Robinson, chief executive of the NC3Rs, said: "If we are to reduce animal use and at the same time continue to develop new treatments for diseases then we must engage the best minds and harness the best science and technology in this endeavour. "That is what we are doing with the ÷£4.5 million in 13 new research projects that the NC3Rs is investing in. We are really pleased to be giving grants to scientists who are trying to develop treatments in major areas of concern such as cancer, motor neurone disease and Alzheimer"s disease. "If they can do this, and reduce their reliance on animal use then this has to be good news." Vicky Just University of Bath


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009